New diabetes combo pill tested in healthy volunteers
NCT ID NCT07511010
First seen Apr 07, 2026 · Last updated May 12, 2026 · Updated 6 times
Summary
This early-stage study tests a new combination pill for type 2 diabetes in 28 healthy Chinese adults. It has two parts: one checks how a high-fat meal changes drug levels in the blood, and the other looks at how the drug builds up with repeated doses. The goal is to gather safety and processing information, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T2DM (TYPE 2 DIABETES MELLITUS) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.